Richard A Malinauskas Selected Research

cellulose acetate-butyrate (C.A.B.)

8/2019

A CFD-based Kriging surrogate modeling approach for predicting device-specific hemolysis power law coefficients in blood-contacting medical devices.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard A Malinauskas Research Topics

Disease

7	Hemolysis 08/2019 - 07/2008
3	Thrombosis (Thrombus) 01/2020 - 01/2013
1	Hematologic Diseases (Blood Diseases) 11/2018

Drug/Important Bio-Agent (IBA)

2	Biocompatible Materials (Biomaterials)IBA 01/2020 - 10/2013
2	Hemoglobins (Hemoglobin)IBA 03/2019 - 11/2018
1	Polyvinyl Chloride (PVC)IBA 01/2020
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2020
1	LatexIBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	cellulose acetate-butyrate (C.A.B.)IBA 08/2019
1	SolutionsIBA 08/2019
1	HaptoglobinsIBA 03/2019
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	polyacrylamideIBA 01/2013
1	HydrogelsIBA 01/2013
1	IonsIBA 09/2011
1	SilverIBA 09/2011
1	SuspensionsIBA 09/2011
1	Citric Acid (Citrate)FDA LinkGeneric 09/2011
1	ChloridesIBA 09/2011
1	Phosphates (Orthophosphate)IBA 09/2011
1	Blood Proteins (Serum Proteins)IBA 09/2011

Therapy/Procedure

2	Protective Devices (Safety Device) 09/2015 - 03/2015
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 03/2019
1	Vena Cava Filters (Inferior Vena Cava Filter) 01/2013
1	Renal Dialysis (Hemodialysis) 07/2008